Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

@article{Randrup2004UptakeIO,
  title={Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression},
  author={Axel Abraham Randrup and Claus Br{\ae}strup},
  journal={Psychopharmacology},
  year={2004},
  volume={53},
  pages={309-314}
}
The dopamine theory of depression was studied by assessing the effect of antidepressant drugs on uptake of dopamine, noradrenaline, and serotonin in synaptosomes from rat brain. Five newer drugs—butriptyline, maprotiline, trimipramine, iprindole, and mianserine—exhibited rather potent inhibition of 3H-dopamine uptake in corpus striatum, as their IC50 values, which were in the order of 10-6–10-5 M, were only about 50 times higher than for nomifensine (IC50=10-7 M). The five drugs were weak… 

Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs

The therapeutic action of antidepressant drugs may in part be due to a reduced functional activity of some central 5-HT systems, and a new indoleamine hypothesis of depression is presented.

Interactions of amineptine with the neuronal dopamine uptake system: Neurochemicalin vitro andin vivo studies

The data indicate that amineptine inhibits DA uptake and is virtually devoid of DA releasing effects, and displays a relatively low affinity for the NE uptake system.

Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin.

The evidence is as yet insufficient to prove the superiority of iprindole over placebo in the treatment of those depressions characterized by endogenous symptoms, but the pharmacological profiles of these two drugs together with their clinical profiles are not inconsistent with the hypothesized role of biogenic amines in major depression.

Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters

Neither trimipramine nor its metabolites are highly potent inhibitors of the examined monoamine transporters, but at a steady state the sum of the concentrations of the parent compound and its active metabolites is almost two times higher than the plasma concentration of trimipramsine.

Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities

Tandamine affects biogenic amine mechanism following either acute or chronic administration in a fashion similar to desipramine, but unlike desipramsine, it exhibits relatively little anticholinergic properties, a further indication of the potential use of tandamine in the treatment of human depression, particularly where an increase in drive is desired.

Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats

Clorgyline induced expected increases in amine levels and decreased acid metabolite levels in accord with previous studies, and CMI induced a decrease in 5-HIAA levels in all regions, although not as pronounced as the decrease observed with CLG.

Regulation of Dopamine Release in the Forebrain by Alpha2 Adrenoceptors and NMDA Glutamate Receptors

The results indicate that in vivo extracellular concentrations of DA in mouse brain reflect neuronal release and are sensitive to activation by unconditioned stimuli such as handling, novel environment and injection stress.

The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition?

The dual effects of intracerebroventricular bupropion on the VTA dopaminergic neurons but solo inhibitory effect of its microiontophoretic application reflect the intra-VTA and extra- VTA heterogenic cellular and molecular control over the dopaminergy outflow that can be mediated by different receptors.

Antidepressants and serotonergic neurotransmission: An integrative review

  • P. Willner
  • Biology, Psychology
    Psychopharmacology
  • 2004
Chronic administration of antidepressants may enhance 5-HT transmission by both pre- and post-synaptic effects, and the relative contributions vary, which supports the classical “indoleamine hypothesis of depression” rather than the more recent “hypersensitive serotonin receptor” theory.
...

References

SHOWING 1-10 OF 85 REFERENCES

Antidepressant drugs affect dopamine uptake.

Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

Nomifensine is a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum and provides a useful tool for investigating the mechanistic aspects of synaptic events.

Comparative pharmacological studies on butriptyline and some related standard tricyclic antidepressants.

Butriptyline was a potent blocker of the arousal reaction induced by physostigmine and reduced rapid eye movement sleep with a conmitant increase in non-rapid eye movementSleep.

The contribution of drug research to investigating the nature of endogenous depression.

A causal relationship between disturbances in monoamine metabolism and depression is suggested by observations on the mode of action of drugs producing or alleviating depressive symptoms.

The contribution of drug research to investigating the nature of endogenous depression.

  • A. Carlsson
  • Psychology, Biology
    Pharmakopsychiatrie, Neuro-Psychopharmakologie
  • 1976
A causal relationship between disturbances in monoamine metabolism and depression is suggested, and 5-hydroxytryptamine is primarily involved in the control of mood, and noradrenaline in psychomotor activity.

Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes

Results indicate that mianserin interferes in a way different from that of tricyclic antidepressants with the neurotransmitter transport mechanisms at the presynaptic level.

Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain

  • B. Leonard
  • Biology, Chemistry
    Psychopharmacologia
  • 2004
It would appear that Org GB 94 is an antidepressant with a neurochemical profile unlike that of the tri-cyclic anti-depressants.
...